Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 18Active not recruiting 11Not yet recruiting 5Terminated 2Suspended 2Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 152Neoplasms 108Carcinoma, Non-Small-Cell Lung 83Colorectal Neoplasms 81Prostatic Neoplasms 80Lung Neoplasms 71Leukemia, Myeloid, Acute 48Carcinoma, Hepatocellular 48Pancreatic Neoplasms 45Neoplasm Metastasis 39Multiple Myeloma 37Recurrence 34Triple Negative Breast Neoplasms 29Squamous Cell Carcinoma of Head and Neck 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Melanoma 27Glioblastoma 27Head and Neck Neoplasms 25Brain Neoplasms 25Uterine Cervical Neoplasms 24Stomach Neoplasms 24Rectal Neoplasms 24Ovarian Neoplasms 24Small Cell Lung Carcinoma 22Carcinoma, Renal Cell 20Lymphoma, B-Cell 19Lymphoma, Follicular 18Lymphoma 18Endometrial Neoplasms 18Glioma 17

Interventions

Nivolumab 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Solid Tumors × 90 days × Clear all
NCT07624864 2026-06-03

A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors

Ganzhou Hemay Pharmaceutical Co., Ltd

Phase 1 Not yet recruiting
24 enrolled
Other solid neoplasm

Solid Tumors

NCT07176975 2026-05-26

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

Boehringer Ingelheim

Phase 1 Not yet recruiting
46 enrolled
Other solid neoplasm

Solid Tumors

NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

GlaxoSmithKline

Phase 1/2 Not yet recruiting
184 enrolled
Other solid neoplasm

Solid Tumors

NCT07583953 2026-05-13

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Suzhou Abogen Biosciences Co., Ltd.

Phase EARLY_PHASE1 Not yet recruiting
50 enrolled
Other solid neoplasm

Solid Tumors

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

RemeGen Co., Ltd.

Phase 1/2 Not yet recruiting
326 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡